In this edition of Moneycontrol Pro Panorama: IEA stresses case for changing energy systems, what the demerger means for Vedanta, ISRO#39;s cost sutting lessons for India Inc, BJP#39;s risky gamble with women’s quota bill, and more

Read More

​ In this edition of Moneycontrol Pro Panorama: IEA stresses case for changing energy systems, what the demerger means for Vedanta, ISRO#39;s cost sutting lessons for India Inc, BJP#39;s risky gamble with women’s quota bill, and more In this edition of Moneycontrol Pro Panorama: IEA stresses case for changing energy systems, what the demerger means for Vedanta, ISRO#39;s cost sutting lessons for India Inc, BJP#39;s risky gamble with women’s quota bill, and more  Moneycontrol Latest News Read More  

In this edition of Moneycontrol Pro Panorama: IEA stresses case for changing energy systems, what the demerger means for Vedanta, ISRO#39;s cost sutting lessons for India Inc, BJP#39;s risky gamble with women’s quota bill, and more

In this edition of Moneycontrol Pro Panorama: IEA stresses case for changing energy systems, what the demerger means for Vedanta, ISRO#39;s cost cutting lessons for India Inc, BJP#39;s risky gamble with women’s quota bill, and more

Read More

​ In this edition of Moneycontrol Pro Panorama: IEA stresses case for changing energy systems, what the demerger means for Vedanta, ISRO#39;s cost cutting lessons for India Inc, BJP#39;s risky gamble with women’s quota bill, and more In this edition of Moneycontrol Pro Panorama: IEA stresses case for changing energy systems, what the demerger means for Vedanta, ISRO#39;s cost cutting lessons for India Inc, BJP#39;s risky gamble with women’s quota bill, and more  Moneycontrol Latest News Read More  

In this edition of Moneycontrol Pro Panorama: IEA stresses case for changing energy systems, what the demerger means for Vedanta, ISRO#39;s cost cutting lessons for India Inc, BJP#39;s risky gamble with women’s quota bill, and more

The market has remained under pressure for a few days now and the trend continued led by selling by foreign institutional investors. India VIX, the measure of expected volatility over the next 30 days, jumped sharply

Read More

​ The market has remained under pressure for a few days now and the trend continued led by selling by foreign institutional investors. India VIX, the measure of expected volatility over the next 30 days, jumped sharply The market has remained under pressure for a few days now and the trend continued led by selling by foreign institutional investors. India VIX, the measure of expected volatility over the next 30 days, jumped sharply  Moneycontrol Latest News Read More  

The market has remained under pressure for a few days now and the trend continued led by selling by foreign institutional investors. India VIX, the measure of expected volatility over the next 30 days, jumped sharply

Defaults are rising but sponsors have the money, tools and motivation to avert disaster

Read More

​ Defaults are rising but sponsors have the money, tools and motivation to avert disaster Defaults are rising but sponsors have the money, tools and motivation to avert disaster  Moneycontrol Latest News Read More  

Defaults are rising but sponsors have the money, tools and motivation to avert disaster

ICICI Securities is bullish on Tatva Chintan Pharma Chem recommended buy rating on the stock with a target price of Rs 2000 in its research report dated September 27, 2023.

Read More

​ ICICI Securities is bullish on Tatva Chintan Pharma Chem recommended buy rating on the stock with a target price of Rs 2000 in its research report dated September 27, 2023. ICICI Securities is bullish on Tatva Chintan Pharma Chem recommended buy rating on the stock with a target price of Rs 2000 in its research report dated September 27, 2023.  Moneycontrol Latest News Read More  

ICICI Securities is bullish on Tatva Chintan Pharma Chem recommended buy rating on the stock with a target price of Rs 2000 in its research report dated September 27, 2023.

Profitmart is bullish on Iris Clothings Ltd has recommended buy rating on the stock with a target price of Rs 105 in its research report dated September 20, 2023.

Read More

​ Profitmart is bullish on Iris Clothings Ltd has recommended buy rating on the stock with a target price of Rs 105 in its research report dated September 20, 2023. Profitmart is bullish on Iris Clothings Ltd has recommended buy rating on the stock with a target price of Rs 105 in its research report dated September 20, 2023.  Moneycontrol Latest News Read More  

Profitmart is bullish on Iris Clothings Ltd has recommended buy rating on the stock with a target price of Rs 105 in its research report dated September 20, 2023.

Happiest Minds shares were down 3.49 percent at Rs 878.95 at 2.21 pm on the National Stock Exchange.

Read More

​ Happiest Minds shares were down 3.49 percent at Rs 878.95 at 2.21 pm on the National Stock Exchange. Happiest Minds shares were down 3.49 percent at Rs 878.95 at 2.21 pm on the National Stock Exchange.  Moneycontrol Latest News Read More  

Happiest Minds shares were down 3.49 percent at Rs 878.95 at 2.21 pm on the National Stock Exchange.

This strategic financial move is aimed at supporting the company#39;s ongoing capital expenditure programme in Bharuch, Gujarat, it said in a statement.

Read More

​ This strategic financial move is aimed at supporting the company#39;s ongoing capital expenditure programme in Bharuch, Gujarat, it said in a statement. This strategic financial move is aimed at supporting the company#39;s ongoing capital expenditure programme in Bharuch, Gujarat, it said in a statement.  Moneycontrol Latest News Read More  

This strategic financial move is aimed at supporting the company#39;s ongoing capital expenditure programme in Bharuch, Gujarat, it said in a statement.

Valiant Laboratories IPO | The pharmaceutical ingredient manufacturing company aims to raise Rs 152.46 crore via maiden public issue of 1.09 crore equity shares comprising only a fresh issue portion.

Read More

​ Valiant Laboratories IPO | The pharmaceutical ingredient manufacturing company aims to raise Rs 152.46 crore via maiden public issue of 1.09 crore equity shares comprising only a fresh issue portion. Valiant Laboratories IPO | The pharmaceutical ingredient manufacturing company aims to raise Rs 152.46 crore via maiden public issue of 1.09 crore equity shares comprising only a fresh issue portion.  Moneycontrol Latest News Read More  

Valiant Laboratories IPO | The pharmaceutical ingredient manufacturing company aims to raise Rs 152.46 crore via maiden public issue of 1.09 crore equity shares comprising only a fresh issue portion.

PG Supply Chain Catalyst Fund will provide an opportunity to startups and innovators to collaborate with Procter Gamble (PG) India on customising business solutions, accelerating its journey towards Supply 3.0 initiatives, said a statement from the company.

Read More

​ PG Supply Chain Catalyst Fund will provide an opportunity to startups and innovators to collaborate with Procter Gamble (PG) India on customising business solutions, accelerating its journey towards Supply 3.0 initiatives, said a statement from the company. PG Supply Chain Catalyst Fund will provide an opportunity to startups and innovators to collaborate with Procter Gamble (PG) India on customising business solutions, accelerating its journey towards Supply 3.0 initiatives, said a statement from the company.  Moneycontrol Latest News Read More  

PG Supply Chain Catalyst Fund will provide an opportunity to startups and innovators to collaborate with Procter Gamble (PG) India on customising business solutions, accelerating its journey towards Supply 3.0 initiatives, said a statement from the company.